PHARMAESSENTIA
Live / Registered — Registered (as of 19 Sept 2023)
What this means for you
Registered since 19 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90045638
- Registration number
- 7170094
- Mark type
- Stylized text
- Filed
- 10 Jul 2020
- Published for opposition
- 18 Oct 2022
- Registered
- 19 Sept 2023
- Attorney of record
- PETER A. CHIABOTTI
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations of biologics containing recombinant protein contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription medical preparations containing ropeginterferon alfa-2b contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics
Owner
- PharmaEssentia Corporation, Taipei, TW
- PharmaEssentia Corporation, Taipei, TW
- PharmaEssentia Corporation, Taipei, TW
Prosecution history
- 19 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 17 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Jun 2023 — USE AMENDMENT FILED
- 29 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jun 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2022 — PUBLISHED FOR OPPOSITION
- 28 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED